Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_assertion type Assertion NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_head.
- NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_provenance.
- NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_assertion evidence source_evidence_literature NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_provenance.
- NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_assertion SIO_000772 18078695 NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_provenance.
- NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_assertion wasDerivedFrom befree-20150227 NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_provenance.
- NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_assertion wasGeneratedBy ECO_0000203 NP864366.RAGlo-DcZJoMdzRrXWYo9cG5PVLQXCEcZI0zpOX4DE6Ac130_provenance.